Soligenix, Inc.
SNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000812796
No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Soligenix, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 20 | 19 | −1 |
| Shares | 1.44M | 897.5K | −546.0K (−37.8%) |
| Value | $1.02M | $500.2K | −$515.1K (−50.7%) |
New holders (2)
Institutions that held Soligenix, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 15,077 | $8.37K | 0.00% |
| Two Sigma Securities, LLC | 13,381 | $7.46K | 0.00% |
Sold out (3)
Institutions that held Soligenix, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Anson Funds Management LP | 514,144 | $361.9K |
| Virtu Financial LLC | 14,144 | $10.0K |
| UBS Group AG | 1,794 | $1.26K |